2,546
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Cell-penetrating Peptides in Vaccine Delivery: facts, Challenges and Perspectives

ORCID Icon &
Pages 465-467 | Received 20 Aug 2019, Accepted 20 Aug 2019, Published online: 29 Aug 2019

References

  • Green M , LoewensteinPM. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell55(6), 1179–1188 (1988).
  • Koren E , ApteA , SawantRR , GrunwaldJ , TorchilinVP. Cell-penetrating tat peptide in drug delivery systems: proteolytic stability requirements. Drug Deliv.18(5), 377–384 (2011).
  • Mitchell DJ , KimDT , SteinmanL , FathmanCG , RothbardJB. Polyarginine enters cells more efficiently than other polycationic homopolymers. J. Pept. Res.56(5), 318–325 (2000).
  • Radis-Baptista G , CampeloIS , MorlighemJERL , MeloLM , FreitasVJF. Cell-penetrating peptides (CPPS): from delivery of nucleic acids and antigens to transduction of engineered nucleases for application in transgenesis. J. Biotechnol.252, 15–26 (2017).
  • Yang JR , LuoYC , ShibuMA , TothI , SkwarczynskiM. Cell-penetrating peptides: Efficient vectors for vaccine delivery. Curr. Drug Deliv.16(5), 430–443 (2019).
  • Madani F , LindbergS , LangelU , FutakiS , GräslundA. Mechanisms of cellular uptake of cell-penetrating peptides. J. Biophys.2011, 414729–414729 (2011).
  • Skwarczynski M , TothI. Peptide-based synthetic vaccines. Chem. Sci.7(2), 842–854 (2016).
  • Azmi F , AhmadFuaad AA , SkwarczynskiM , TothI. Recent progress in adjuvant discovery for peptide-based subunit vaccines. Hum. Vaccin. Immunother.10(3), 778–796 (2014).
  • Tang J , YinR , TianYet al. A novel self-assembled nanoparticle vaccine with HIV-1 tat(49-57)/HPV e7(49-57) fusion peptide and GM-CSF DNA elicits potent and prolonged CD8(+) t cell-dependent anti-tumor immunity in mice. Vaccine30(6), 1071–1082 (2012).
  • Marasini N , GiddamAK , BatzloffMR , GoodMF , SkwarczynskiM , TothI. Poly-L-lysine-coated nanoparticles are ineffective in inducing mucosal immunity against group a streptococcus. Bio. Chem. Comp.5(1), 1–6 (2017). https://doi.org/10.7243/2052-9341-7245-7241
  • Nevagi RJ , SkwarczynskiM , TothI. Polymers for subunit vaccine delivery. Eur. Polym. J.114, 397–410 (2019).
  • Skwarczynski M , TothI. Recent advances in peptide-based subunit nanovaccines. Nanomedicine (Lond.)9, 2657–2669 (2014).
  • Mohri K , MiyataK , EgawaTet al. Effects of the chemical structures of oligoarginines conjugated to biocompatible polymers as a mucosal adjuvant on antibody induction in nasal cavities. Chem. Pharm. Bull.66(4), 375–381 (2018).
  • Schutze-Redelmeier M-PM , KongS , BallyMB , DutzJP. Antennapedia transduction sequence promotes anti tumour immunity to epicutaneously administered CTL epitopes. Vaccine22(15), 1985–1991 (2004).
  • Ji Z , XieZ , ZhangZ , GongT , SunX. Engineering intravaginal vaccines to overcome mucosal and epithelial barriers. Biomaterials128, 8–18 (2017).
  • Yu X , WangY , XiaY , ZhangL , YangQ , LeiJ. A DNA vaccine encoding VP22 of herpes simplex virus type I (HSV-1) and oprf confers enhanced protection from Pseudomonas aeruginosa in mice. Vaccine34(37), 4399–4405 (2016).
  • Mardani G , BolhassaniA , AgiE , ShahbaziS , MehdiSadat S. Protein vaccination with HPV16 e7/PEP-1 nanoparticles elicits a protective T-helper cell-mediated immune response. IUBMB Life68(6), 459–467 (2016).
  • Saleh T , BolhassaniA , ShojaosadatiSA , AghasadeghiMR. MPG-based nanoparticle: an efficient delivery system for enhancing the potency of DNA vaccine expressing hpv16e7. Vaccine33(28), 3164–3170 (2015).
  • Tripathi PP , AramiH , BangaI , GuptaJ , GandhiS. Cell penetrating peptides in preclinical and clinical cancer diagnosis and therapy. Oncotarget9(98), 37252–37267 (2018).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.